Internal Medicine, Medical Oncology · Houston, TX
NPI
1558457028
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
334 services
Medicare patients, 2024
166
Average age 72
Drug cost, 2024
$4.8M
533 prescriptions
Company payments, 2025
$108K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric Jonasch was code 99215 (office e&m - established), 125 times for 69 patients. In total Eric Jonasch billed 334 services in 16 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 125 | 69 | $104.18 | $13K |
| 99214 Office E&M - Established | Office | 62 | 41 | $94.85 | $5,880 |
| 99214 Office E&M - Established | Facility | 38 | 30 | $73.94 | $2,810 |
| 99213 Office E&M - Established | Office | 20 | 15 | $69.56 | $1,391 |
| 99202 Office E&M - New | Office | 13 | 13 | $54.79 | $712 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $137.84 | $1,516 |
By year: 2022 $38K for 409 services; 2023 $35K for 398 services; 2024 $31K for 334 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eric Jonasch prescribed most often to Medicare patients was Cabometyx (Cabozantinib S-Malate), with 81 prescriptions and refills. In total Eric Jonasch wrote 533 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabometyx Cabozantinib S-Malate | 81 | 81 | 15 | $2.0M |
| Lenvima Lenvatinib Mesylate | 61 | 63 | 12 | $1.5M |
| Welireg Belzutifan | 44 | 44 | Under 11 | $1.2M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 37 | 37 | Under 11 | $1,123 |
| Everolimus Generic | 33 | 35 | Under 11 | $83K |
| Levothyroxine Sodium Generic | 19 | 35 | Under 11 | $180 |
| Pantoprazole Sodium Generic | 17 | 17 | Under 11 | $95.01 |
| Eliquis Apixaban | 15 | 15 | Under 11 | $8,993 |
| Dexamethasone Generic | 15 | 16 | 11 | $277 |
| Ondansetron Odt Ondansetron | 13 | 13 | Under 11 | $311 |
| Alprazolam Generic | 13 | 13 | Under 11 | $47.58 |
| Diazepam Generic | 13 | 13 | Under 11 | $57.73 |
| Sunitinib Malate Generic | 12 | 12 | Under 11 | $50K |
| Methylphenidate Hcl Generic | 12 | 12 | Under 11 | $251 |
| Gabapentin Generic | 11 | 13 | Under 11 | $97.14 |
Brand drugs: 227 claims; generic drugs: 306 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric Jonasch $108K ($108K in general payments such as food, travel and fees) from 11 companies. The largest payer was Merck Sharp & Dohme LLC with $54K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 38 | $54K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $37K |
| Eisai Inc. 4523.T | 5 | $5,494 |
| Telix Pharmaceuticals TLX | 4 | $3,159 |
| Eisai Co., Ltd. 4523.T | 1 | $2,910 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $2,434 |
| Orion Corporation | 1 | $1,500 |
| Exelixis Inc. EXEL | 23 | $770 |
| Ipsen Pharma SAS IPN.PA | 1 | $653 |
| Aveo Pharmaceuticals, Inc. | 4 | $367 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.